Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A Temporal Perspective on the Interplay of Demography and Selection on Deleterious Variation in Humans.
Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
FAK and paxillin, two potential targets in pancreatic cancer.
Glycogen Phosphorylase, Muscle Form
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FAK and paxillin, two potential targets in pancreatic cancer.
FAK and paxillin, two potential targets in pancreatic cancer. Oncotarget. 2016 May 24; 7(21):31586-601.
View in:
PubMed
subject areas
Biomarkers, Tumor
Carcinoma, Pancreatic Ductal
Focal Adhesion Kinase 1
Humans
Models, Biological
Molecular Targeted Therapy
Pancreatic Neoplasms
Paxillin
Protein Kinase Inhibitors
Signal Transduction
authors with profiles
Ravi Salgia